Page 3 - Humanity Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GeroSense AI tracks biological age and resilience via smartphone sensor data Gero has developed and validated GeroSense AI to track biological age and resilience via smartphone sensor data. The performance of the new health and aging markers have been recently reported in a paper in Aging US. Background Many health apps on our smartphones now provide motivations and compliance metrics for specific health goals. The goals usually are physical activity levels, healthy diet, maintaining healthy sleep, or weight loss. Physical activity levels, however, dropped dramatically during lockdowns in 20...

Credit: GERO PTE. LTD. Gero has developed and validated GeroSense AI to track biological age and resilience via smartphone sensor data. The performance of the new health and aging markers have been recently reported in a paper in Background Many health apps on our smartphones now provide motivations and compliance metrics for specific health goals. The goals usually are physical activity levels, healthy diet, maintaining healthy sleep, or weight loss. Physical activity levels, however, dropped dramatically during lockdowns in 2020, and this was not good for health. It is not surprising then,...

Longevity startup Gero AI has a mobile API for quantifying health changes Sensor data from smartphones and wearables can meaningfully predict an individual’s ‘biological age’ and resilience to stress, according to Gero AI. The ‘longevity’ startup — which condenses its mission to the pithy goal of “hacking complex diseases and aging with Gero AI” — has developed an AI model to predict morbidity risk using ‘digital biomarkers’ that are based on identifying patterns in step-counter sensor data which tracks mobile users’ physical activity. A simple measure of ‘steps’ i...

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. Longevica says it has attracted a total of $13 million from investors, including Alexander Chikunov, a longevity investor, who is also president of the company. Longevica says it created a biotechnology platform for […]